ANO1 and breast cancer: ANO1 overexpression is also correlated with poor prognosis of HNSCC and breast cancer patients [30, 34], and pharmacological inhibition of CaCC ANO1 activity by CaCCinh-A01 and T16Ainh-A01 can inhibit cancer cell proliferation [32, 35, 36].